Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Aptamer Group, Neuro-Bio Develop Alzheimer's Early Detection Test, Ink Royalty Agreement
The UK-based firms said that they expect within the next 18 months to deliver a prototype of their ELISA test to a manufacturer or distributor.
Neurodegenerative Disease Testing Firm CND Life Sciences Nabs $8.6M in Series A3 Round
The firm raised a total of $13.5 million in its Series A equity financing round, which will go toward growing and advancing its neurodegenerative disease testing business.
With New Data Validating Blood-Based Alzheimer's Tests, Roche Eyes Possible Launch by End of Year
Premium
The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.
Alzheimer's Disease Studies Outline CSF, Blood Markers for Cognitive Symptoms, Tau Pathology
New research linked cognitive impairment symptoms to a synapse protein ratio in cerebrospinal fluid, while underscoring tauopathy ties to blood plasma levels of eMTBR-tau243.
Ontario Brain Institute, EpiSign Partner on Rare Genetic Disorder Diagnosis
OBI's Center for Analytics and EpiSign will refine and validate EpiSign's machine-learning algorithm that analyzes a person's epigenome to detect rare genetic disorders.